Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Jaume Capdevila
26 years of experience
accreditations :
Clinic is certified :
| Turkey | Austria | Spain | |
| Immunotherapy | from $2,200 | from $30,000 | from $12,000 |
| Sarcoma Immunotherapy | from $18,000 | from $60,000 | from $80,000 |
| Immunotherapy for prostate cancer | from $12,000 | from $30,000 | from $35,000 |
| Immunotherapy for lung cancer | from $18,000 | from $30,000 | from $30,000 |
| Immunotherapy for breast cancer | from $9,500 | from $35,000 | from $45,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).
Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.
Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.
Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.
Written by Kateryna Zamkovska